Superworth

Curis EPS CRIS

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$14.22
Latest quarter, Q2 FY26
−$4.02
Fiscal year 2025
−$23.81

Curis' earnings per share was −$14.22 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$4.02.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$23.81n/a
FY2024−$140.60n/a
FY2023−$180.40n/a
FY2022−$243.60n/a
FY2021−$200.00n/a
FY2020−$268.00n/a
FY2019−$388.00n/a
FY2018−$396.00n/a
FY2017−$728.00n/a
FY2016−$900.00n/a
FY2015−$1000.00n/a
FY2014−$420.00n/a
FY2013−$300.00n/a
FY2012−$400.00n/a
FY2011−$240.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$4.02n/a−$14.22
Q1 FY26−$25.00n/a−$23.81
Q4 FY25$24.60n/a−$23.81
Q3 FY25−$9.80n/a−$73.41
Q2 FY25−$13.61n/a−$97.61
Q1 FY25−$25.00n/a−$124.60
Q4 FY24−$25.00n/a−$140.60
Q3 FY24−$34.00n/a−$156.20
Q2 FY24−$40.60n/a−$164.80
Q1 FY24−$41.00n/a−$173.60
Q4 FY23−$40.60n/a−$180.40
Q3 FY23−$42.60n/a−$186.80

Against its peers

Companies in Biotechnology nearest Curis' size, closest first, today.

CompanyEPS, 12 months
CRISCuris−$14.22
SLXNSilexion Therapeuticsn/m
CLDICalidi Biotherapeutics−$54.30
VIVSVivoSim Labs, INC.−$4.45
PMCBPharmaCyte Biotech−$2.40
LIMNLiminatus Pharma−$21.50
AIMAIM ImmunoTech−$1.00
CELZCreative Medical Technology−$1.97
SNTISenti Biosciences−$1.77
INABIN8BIO−$2.06
INTSIntensity Therapeutics−$4.89
Peer median−$2.40

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Curis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.